FilingReader Intelligence

Sun Pharma appoints Ganorkar as CEO, Shanghvi executive chairman

June 27, 2025 at 09:01 AM UTCBy FilingReader AI

Sun Pharmaceutical Industries (BSE:SUNPHARMA) announced Kirti Ganorkar's appointment as Managing Director, effective September 1, 2025, succeeding Dilip Shanghvi, who will transition to the role of Executive Chairman. Ganorkar, who currently heads Sun Pharma's India Business, has held various leadership positions within the company. Shanghvi will focus on strengthening the company's specialty portfolio and long-term strategy.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Sun Pharmaceutical Industries publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →